tradingkey.logo
tradingkey.logo
Search

Autonomix Medical Inc

AMIX
Add to Watchlist
6.621USD
-0.279-4.05%
Close 07/02, 13:00ETQuotes delayed by 15 min
75.54MMarket Cap
LossP/E TTM

More Details of Autonomix Medical Inc Company

Autonomix Medical, Inc. is a medical device company focused on advancing technologies to develop how diseases involving the nervous system are diagnosed and treated. The Company’s first-in-class platform system technology includes a catheter-based microchip sensing array that may have the ability to detect and differentiate neural signals with greater sensitivity. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform to address dozens of potential indications, including cardiology, hypertension and chronic pain management, across a wide disease spectrum. Its development efforts are divided into two parts: diagnostic sensing and therapeutic radiofrequency ablation. The Company is developing Autonomix system, which is primarily catheter-based, meaning that its sensing equipment is delivered to its targeted location via a lumen within the body.

Autonomix Medical Inc Info

Ticker SymbolAMIX
Company nameAutonomix Medical Inc
IPO dateJan 29, 2024
CEOHauser (Bradley)
Number of employees8
Security typeOrdinary Share
Fiscal year-endJan 29
Address21 Waterway Ave, Suite 300
CityTHE WOODLANDS
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code77380
Phone18322777816
Websitehttps://autonomix.com/
Ticker SymbolAMIX
IPO dateJan 29, 2024
CEOHauser (Bradley)

Company Executives of Autonomix Medical Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
4.83K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
1.70K
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
740.00
+29.32%
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
179.00
--
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Jonathan P. Foster
Mr. Jonathan P. Foster
Independent Director
Independent Director
--
--
Ms. Lori H. Bisson
Ms. Lori H. Bisson
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
--
--
Dr. Christopher Capelli, M.D.
Dr. Christopher Capelli, M.D.
Independent Director
Independent Director
--
--
Ms. Jenene Thomas
Ms. Jenene Thomas
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
4.83K
--
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
1.70K
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
740.00
+29.32%
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
179.00
--
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
--
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--

FAQs

Who are the top five shareholders of Autonomix Medical Inc?

The top five shareholders of Autonomix Medical Inc are: Mr. Landy Toth

How many institutions hold shares of Autonomix Medical Inc (AMIX)?

As of 2026Q1, 42 institutions hold shares of Autonomix Medical Inc, with a combined market value of approximately 319.97K, accounting for 2.80% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -276558.00.